ERCC6 expression is frequently upregulated in cancer cells, favoring cancer cell proliferation while suppressing apoptosis, which has been recognized as a promising actionable target for cancer treatment (Proietti-De-Santis et al., 2018). Here, ERCC6 is linked to cancer.